Просмотр новости
Найдите то, что Вас интересует
Спутники
РН
SpaceX
Роскосмос
NASA
Animal Genetics Market by Live Animal (Bovine, Porcine, Canine), Products & Services (Genetic Materials (Semen, Embryo), Genetic Testing Services (Disease Tests, Trait Tests), Technology (PCR, NGS, rDNA), End User (Animal Farm) - Global Forecast to 2031..., Market Research Report: MarketsandMarkets
Дата публикации: 31-07-2026 00:00:00
Основное содержимое страницы с новостью.
Animal Genetics Market by Live Animal (Bovine, Porcine, Canine), Products & Services (Genetic Materials (Semen, Embryo), Genetic Testing Services (Disease Tests, Trait Tests), Technology (PCR, NGS, rDNA), End User (Animal Farm) - Global Forecast to 2031
2026-2031
FORECAST PERIOD
ANIMAL GENETICS MARKET SIZE, SHARE & GROWTH SNAPSHOT
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The global animal genetics market is projected to grow from USD 6.64 billion in 2026 to USD 9.37 billion by 2031, at a CAGR of 7.1% during the forecast period. The market was valued at USD 6.24 billion in 2025. Growth is driven by rising consumption of high-quality animal-derived protein and dairy products, a growing focus on animal health, livestock productivity, and breeding efficiency, and the prevention of genetic diseases through advanced genetics services. Wider adoption of molecular and genomic tools across livestock improvement programs is adding further momentum. In addition, the integration of advanced phenotyping technologies with genomic selection programs and rising investment in animal genetics research are accelerating the use of genetic materials and testing services across farms, veterinary networks, and diagnostic centers.
KEY TAKEAWAYS
-
MARKET SNAPSHOT:
Base Year Market Size (2025): USD 6.24 Billion
Current Market Size (2026): USD 6.64 Billion
Forecast Market Size (2031): USD 9.37 Billion
CAGR (2026–2031): 7.1% -
SEGMENT LEADERSHIP:
Product Leader: Animal genetic materials accounted for the largest share of 71.6% in 2025, driven by their extensive use in artificial insemination, embryo transfer, and livestock breeding programs.
Animal Type Leader: Poultry segment accounted for the largest share of the live animal segment at 32.7% in 2025.
Technology Leader: PCR segment accounted for the largest share of the technology market at 27.7% in 2025.
End User Leader: Diagnostic centers segment is projected to register the highest CAGR of 5.0% during the forecast period. -
MARKET OUTLOOK & COMPETITIVE LANDSCAPE:
Genus Plc (UK), Urus Group LP (US), Hendric Genetics BV (Netherlands), Topigs Norsvin EN (Netherlands), and CRV (Netherlands) are among the major players in the animal genetics market, with their comprehensive portfolios, strong focus on genomic selection, and advanced sequencing, reproductive technologies, and precision breeding solutions.
Inguran LLC DBA STgenetics (US), DanBred P/S (Denmark), and Laboklin GmbH & Co. KG (Germany) are among the emerging players in the animal genetics market, focusing on differentiated genetic technologies and specialized breeding solutions for livestock and companion animals.
Rising global demand for high-quality animal protein, increasing adoption of genomic selection and assisted reproductive technologies, and growing emphasis on improving livestock productivity, disease resistance, and breeding efficiency are driving investment in animal genetics. Advances in next-generation sequencing (NGS), artificial intelligence (AI)-enabled breeding, genomic evaluation, and reproductive technologies are accelerating genetic gain and improving breeding outcomes. As commercial livestock production expands and breeding programs become increasingly data-driven, demand for high-performance genetic materials and precision breeding solutions is expected to grow steadily.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The figure highlights how the animal genetics market is evolving from conventional genetic testing and parentage verification toward integrated genomics, precision breeding, and AI-enabled genetic improvement solutions. Earlier approaches primarily focused on selective breeding and basic molecular diagnostics. Newer technologies increasingly incorporate next-generation sequencing (NGS), genomic selection, bioinformatics, AI-driven breeding analytics, reproductive genomics, and gene-editing technologies such as CRISPR to accelerate genetic gain and improve breeding accuracy. Supported by integrated genomic and phenotypic data platforms, these capabilities enable improved disease resistance, fertility, feed efficiency, productivity, and sustainability, helping livestock producers and breeding organizations make faster, data-driven breeding decisions while enhancing long-term animal performance and resource efficiency.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
OPPORTUNITIES
Impact
Level
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The global demand for high-quality animal protein and dairy keeps climbing as diets shift toward greater protein intake across both developed and emerging markets. Producers are responding by investing in genetics that raise output per animal, since genetic selection remains one of the most cost-effective levers for improving milk yield, growth rate, and feed conversion. This demand pull extends across poultry, swine, and bovine operations alike, and runs alongside a parallel focus on improving animal health and breeding efficiency through genomic tools. Disease prevention adds a second growth vector, as genetics providers increasingly frame testing services around screening out hereditary conditions before they affect a herd. Together, these forces are pushing molecular and genomic tools into mainstream livestock improvement programs rather than keeping them a specialist add-on.
Advanced genetic testing, particularly NGS and comprehensive genomic panels, remains out of reach for many smaller producers, especially in developing regions where margins are thin. This cost sensitivity limits broader adoption of animal genetic services beyond larger, better-capitalized operations. Technical limitations in the accuracy and interpretation of genetic testing technologies compound the issue: producers willing to pay for testing do not always get results they can act on with full confidence. Smaller diagnostic labs face a related challenge, since building the bioinformatics expertise needed to interpret complex genomic data requires investment that is hard to justify at current test volumes. Failures, driven by strict regulatory scrutiny from agencies such as the FDA and CDSCO. Because vascular access devices are in direct contact with blood, malfunctions can cause serious complications such as infection, thrombosis, and, in severe cases, death. Recalls across multiple regions have adversely affected market growth and manufacturer reputation.
Large parts of the developing world still rely on breeding practices with limited access to modern testing infrastructure, leaving considerable headroom for providers willing to build out local laboratory capacity and distribution networks. Integration of advanced phenotyping technologies with genomic selection programs offers a second opening, since combining on-farm trait data with genomic breeding values improves selection accuracy in ways neither approach delivers alone. Rising investment in animal genetics research and product innovation is funding this kind of integration work, giving providers with strong R&D pipelines a chance to differentiate on technical capability rather than price. Vendors that can package affordable, standardized testing products for price-sensitive markets stand to capture a disproportionate share of this growth.
Locally adapted breeds often carry traits, such as disease resistance or heat tolerance, that make them valuable in specific environments but poorly served by generic, imported breeding programs. Building breed-specific genetic improvement programs for these populations requires dedicated research investment and local breeding infrastructure that many providers have been slow to develop. A shortage of technical expertise among animal genetics professionals in the regions where locally adapted breeds are most common compounds the problem, limiting how quickly testing and breeding programs can scale even where the underlying science exists. Vendors that invest early in local technical training and breed-specific research may be better placed to serve these markets as they open up.
ANIMAL GENETICS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
|
|
ISA and Bovans layer genetics, Hybrid Turkeys, and Hypor swine breeding programs combine genomic selection, pedigree evaluation, and performance testing to develop elite breeding stock for commercial poultry and swine production. | Improves egg production, feed conversion, fertility, growth performance, robustness, and disease resilience while supporting sustainable livestock production. |
|
|
Commercial breeding lines including TN70, TN Tempo, and Norsvin Duroc utilize genomic selection, CT-based carcass evaluation, and nucleus breeding programs to optimize commercial pig production. | Delivers larger litters, superior feed efficiency, improved carcass quality, faster growth rates, and greater sow longevity, enhancing producer profitability. |
|
|
Through ABS Global and PIC, the company provides elite bovine semen, genomic mating programs, Sexcel sexed semen technology, and high-performance swine breeding stock for dairy, beef, and pork production. | Accelerates genetic gain, improves conception rates, enhances milk and meat productivity, and strengthens herd health and reproductive efficiency. |
|
|
Through Alta Genetics, GENEX, PEAK, and VAS, URUS integrates elite sire genetics, genomic evaluations, embryo transfer, and herd management technologies for dairy and beef cattle improvement. | Enables data-driven breeding decisions that improve fertility, milk yield, beef performance, genetic merit, and long-term herd profitability. |
|
|
Combines genomic evaluation, herd recording, artificial insemination, and customized breeding programs to optimize dairy and beef cattle genetics based on farm-specific breeding objectives. | Improves lifetime milk production, fertility, udder health, longevity, and feed efficiency while reducing replacement costs and increasing overall herd productivity. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The animal genetics ecosystem consists of genetic material producers (semen, embryos), genomics and molecular technology providers, breeding companies, genetic testing laboratories, regulatory authorities, distributors, and end users such as animal farms, veterinary hospitals & clinics, diagnostic centers, and research institutes. Market participants increasingly focus on genomic selection, advanced reproductive technologies, next-generation sequencing (NGS), AI-enabled breeding, and precision livestock genetics, while regulatory agencies, breed associations, and animal breeding standards guide the development, commercialization, and adoption of genetic materials and testing services.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Poultry holds the leading share, driven by large-scale commercial breeding, short production cycles, and continuous genetic improvement programs aimed at enhancing productivity and feed efficiency, while canine is the fastest-growing segment, supported by increasing pet ownership, rising demand for breed verification and inherited disease screening, and growing adoption of companion animal genetic testing.
Animal genetic materials account for the largest share, driven by their widespread use in livestock breeding programs, artificial insemination, and embryo transfer, while genetic testing services are the fastest-growing segment, supported by increasing adoption of genomic selection, parentage verification, and trait identification.
NGS holds the largest share, driven by its expanding use in genomic selection, trait discovery, disease resistance analysis, and whole-genome characterization, while other technologies are the fastest-growing segment, supported by increasing adoption of SNP genotyping, microsatellite (STR) analysis, DNA sequencing, and Sanger sequencing for parentage verification, genetic evaluation, and precision breeding applications.
Animal farms account for the largest share due to the increasing adoption of genetic improvement programs, artificial insemination, and embryo transfer technologies to enhance livestock productivity, while diagnostic centers are the fastest-growing end users, supported by rising demand for genomic testing, parentage verification, inherited disease screening, and trait identification across livestock and companion animals.
REGION
Europe to hold the largest share of the global animal genetics market
Europe dominates the animal genetics market due to its well-established livestock breeding programs, widespread adoption of genomic selection and advanced reproductive technologies, and the strong presence of leading animal genetics product and service manufacturers. The region also benefits from advanced veterinary infrastructure, substantial investments in precision breeding, and increasing demand for high-genetic-merit livestock to improve productivity, herd health, and production efficiency.
ANIMAL GENETICS MARKET: COMPANY EVALUATION MATRIX
In the animal genetics market matrix, Hendrix Genetics (Star) leads through its diversified multi-species breeding portfolio, strong global breeding network, and continuous investments in genomic selection and reproductive technologies. Topigs Norsvin EN (Emerging Leader) is strengthening its position through advanced swine genetics, data-driven breeding programs, and continuous innovation in genomic selection, enabling superior productivity, feed efficiency, and herd performance for commercial pork producers.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2025 (Value) | USD 6.24 Billion |
| Market Size in 2026 (Value) | USD 6.64 Billion |
| Market Forecast in 2031 (Value) | USD 9.37 Billion |
| Growth Rate | CAGR of 7.1% from 2026–2031 |
| Years Considered | 2024–2031 |
| Base Year | 2025 |
| Forecast Period | 2026–2031 |
| Units Considered | Value (USD Billion)/Volume (Thousand/Million Units) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments Covered |
|
| Regions Covered | North America, Europe, Asia Pacific, Middle East & Africa, Latin America |
WHAT IS IN IT FOR YOU: ANIMAL GENETICS MARKET REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Product Analysis | Compared key animal genetics products and services, including semen, embryos, live breeding animals, genetic testing services, and genomic technologies such as Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Short Tandem Repeat (STR) Analysis, DNA Typing, and Sanger Sequencing. Evaluated technology adoption, reproductive technologies, breeding innovations, and species-wise demand across livestock and companion animals. | Enabled identification of high-growth product categories, technology adoption trends, and innovation opportunities; supported product portfolio optimization, technology benchmarking, and strategic investment decisions aligned with evolving breeding and livestock productivity requirements. |
| Company Information | Profiled leading and emerging market participants based on their product and service portfolios, breeding technologies, research and development capabilities, geographic presence, strategic partnerships, mergers and acquisitions, innovation initiatives, and competitive positioning across the animal genetics value chain. | Provided insights into the competitive landscape, technology differentiation, market positioning, and expansion strategies; supported vendor benchmarking, partnership evaluation, competitive intelligence, and identification of collaboration and investment opportunities. |
| Geographic Analysis | Conducted region-wise analysis across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, evaluating livestock demographics, breeding infrastructure, adoption of genomic technologies, regulatory frameworks, government livestock improvement initiatives, trade dynamics, and investment activity influencing regional market growth. | Supported regional expansion strategies by identifying high-growth markets, evaluating breeding ecosystems and regulatory environments, assessing localization opportunities, and prioritizing investments based on regional demand, commercial livestock production, and genetic improvement initiatives. |
RECENT DEVELOPMENTS
- January 2026 : Hendrix Genetics BV partnered with Huanshan Group to establish a high-biosecurity swine nucleus breeding farm in China. The collaboration strengthens the company's breeding infrastructure in Asia, expands the production of elite breeding stock, and supports the delivery of high-performance, disease-resilient swine genetics tailored to the growing demand of the Chinese pork industry.
- May 2025 : URUS Group LP entered into a definitive agreement to acquire AgriWebb, a global livestock management and supply chain platform. The acquisition expands URUS' digital livestock ecosystem by integrating herd management, production records, and genetic data with its bovine genetics and reproductive technologies. The move strengthens the company's precision livestock capabilities, enabling producers to make more informed breeding, herd performance, and operational decisions across the global beef industry.
- January 2025 : Genus plc received approval from the US Food and Drug Administration for its PRRS-resistant pig (PRP) gene edit, clearing the trait for use in the US food supply chain. The company reported continuing regulatory progress in Canada, Mexico, and Japan for the same trait. Genus also announced an accelerated Chinese joint venture with Beijing Capital Agribusiness to bring the PRP trait to the Chinese pork market.
- August 2024 : CRV entered into a collaboration with VikingGenetics to exchange genotypes on Holstein breeding candidates and jointly advance their respective Holstein breeding programs. The two cooperatives also agreed to explore collaboration on breeding traits related to methane emissions. CRV said the partnership widens the genetic range available to customers of both organizations and strengthens the underlying databases used for genetic evaluation.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
4
MARKET OVERVIEW
Unlock growth by leveraging genomic tools and untapped market potential in animal genetics.47
4.2.1.1
INCREASING CONSUMPTION OF HIGH-QUALITY ANIMAL-DERIVED PROTEIN AND DAIRY PRODUCTS
4.2.1.2
RISING FOCUS ON IMPROVING ANIMAL HEALTH, LIVESTOCK PRODUCTIVITY AND BREEDING EFFICIENCY THROUGH ANIMAL GENETICS
4.2.1.3
PREVENTION OF GENETIC DISEASES THROUGH ADVANCED GENETIC SERVICES
4.2.1.4
GROWING ADOPTION OF MOLECULAR AND GENOMIC TOOLS IN LIVESTOCK IMPROVEMENTS
4.2.2.1
HIGH COST ASSOCIATED WITH ADVANCED GENETIC TESTING LIMITING ADOPTION OF ANIMAL GENETIC SERVICES
TECHNICAL LIMITATIONS IN ACCURACY AND INTERPRETATION OF GENETIC
4.2.3.1
UNTAPPED MARKET POTENTIAL IN DEVELOPING COUNTRIES
4.2.3.2
INTEGRATION OF ADVANCED PHENOTYPING TECHNOLOGIES WITH GENOMIC SELECTION PROGRAMS
RISING INVESTMENTS IN ANIMAL GENETICS RESEARCH AND
4.2.4.1
DEVELOPING BREED-SPECIFIC GENETIC IMPROVEMENT PROGRAMS FOR LOCALLY ADAPTED ANIMAL POPULATIONS
4.2.4.2
LACK OF TECHNICAL EXPERTISE AMONG ANIMAL GENETICS PROFESSIONALS
4.3
UNMET NEEDS AND WHITE SPACES
4.3.1
UNMET NEEDS IN ANIMAL GENETICS MARKET
4.3.2
WHITE SPACE OPPORTUNITIES
4.4
INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
4.4.1
INTERCONNECTED MARKETS
4.4.2
CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Navigate competitive pressures and pricing trends to seize opportunities in animal healthcare and medical devices.61
5.1
PORTER’S FIVE FORCES ANALYSIS
5.1.1
THREAT OF NEW ENTRANTS
5.1.2
THREAT OF SUBSTITUTES
5.1.3
BARGAINING POWER OF BUYERS
5.1.4
BARGAINING POWER OF SUPPLIERS
5.1.5
INTENSITY OF COMPETITIVE RIVALRY
5.2
MACROECONOMIC INDICATORS
5.2.2
GDP TRENDS & FORECAST
5.2.3
TRENDS IN GLOBAL ANIMAL HEALTHCARE INDUSTRY
5.2.4
TRENDS IN GLOBAL ANIMAL MEDICAL DEVICE INDUSTRY
5.3
SUPPLY CHAIN ANALYSIS
AVERAGE SELLING PRICE TREND OF KEY PLAYERS,
5.6.2
AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TECHNOLOGY MARKET
5.6.3
AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END USER
5.6.4
AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION
5.7.1
TRADE DATA FOR HS CODE 051110
5.7.1.1
IMPORT DATA FOR HS CODE 051110
5.7.1.2
EXPORT DATA FOR HS CODE 051110
5.8
KEY CONFERENCES & EVENTS
5.9
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.10
INVESTMENT & FUNDING SCENARIO
5.12
IMPACT OF 2025 US TARIFFS – ANIMAL GENETICS MARKET
5.12.3
PRICE IMPACT ANALYSIS
5.12.4
IMPACT ON COUTRY/REGION
5.12.5
IMPACT ON END-USE INDUSTRIES
5.12.5.2
VETERINARY HOSPITALS AND CLINICS
5.12.5.3
DIAGNOSTICS CENTER
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS AND FUTURE APPLICATIONS
AI and CRISPR-Cas9 revolutionize precision breeding and climate-resilient livestock innovations.86
6.1
KEY EMERGING TECHNOLOGIES
6.1.1
CRISPR-CAS9 GENE EDITING
6.1.2
PRECISION PHENOTYPING
6.2
COMPLEMENTARY TECHNOLOGIES
6.2.1
ARTIFICIAL INSEMINATION
6.2.2
EMBRYO TRANSFER TECHNOLOGY
6.3
ADJACENT TECHNOLOGIES
6.3.1
ARTIFICIAL INTELLIGENCE (AI)
6.3.2
PRECISION LIVESTOCK FARMING
6.4
TECHNOLOGY/PRODUCT ROADMAP
6.4.1
NEAR TERM (2025–2027)
6.4.2
MID-TERM (2028–2030)
6.5.1
JURISDICTION & TOP APPLICANT ANALYSIS
6.6.1
PRECISION BREEDING AND GENOMIC SELECTION
6.6.2
DEVELOPMENT OF DISEASE-RESISTANT AND HEALTHIER ANIMAL BREEDS
6.6.3
CLIMATE-RESILIENT LIVESTOCK PRODUCTION
CONSERVATION AND RESTORATION OF VALUABLE ANIMAL
PERSONALIZED BREEDING PROGRAMS USING AI AND GENOMIC
6.7
IMPACT OF AI/GENERATIVE AI ON ANIMAL GENETICS MARKET
6.7.1
TOP USE CASES AND MARKET POTENTIAL
6.7.2
BEST PRACTICES IN ANIMAL GENETICS MARKET
6.7.3
CASE STUDIES OF AI IMPLEMENTATION IN ANIMAL GENETICS MARKET
6.7.4
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS – ANIMAL GENETICS MARKET
6.7.5
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN THE ANIMAL GENETICS
7
SUSTAINABILITY & REGULATORY LANDSCAPE
Navigate complex global regulations and standards to drive sustainability in animal genetics.103
7.1
REGIONAL REGULATIONS & COMPLIANCE
7.1.1
REGULATORY ANALYSIS
7.1.2
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.2.1
TESTING LABORATORY COMPETENCE STANDARD – ISO/IEC 17025:2017
7.2.2
QUALITY MANAGEMENT SYSTEM STANDARD – ISO 9001:2015
7.2.3
BIOBANKING OF ANIMAL GERMPLASM STANDARD – ISO 16677-1:2025
7.2.4
BIOTECHNOLOGY — BIOPROCESSING STANDARD – ISO 20688-1:2024
7.2.5
INFORMATION SECURITY MANAGEMENT STANDARD – ISO/IEC 27001:2022
7.3
SUSTAINABILITY INITIATIVES
SUSTAINABLE ANIMAL HEALTH AND GENETICS INNOVATION -
7.3.2
ADVANCING SUSTAINABILITY THROUGH ANIMAL GENETICS – GENUS PLC
7.3.3
SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
7.3.4
CERTIFICATIONS, LABELING, AND ECO-STANDARDS
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
Unlock profitability by understanding stakeholder influence and unmet needs in the animal genetics market.112
8.1
DECISION-MAKING PROCESS
8.2
KEY STAKEHOLDERS & BUYING CRITERIA
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9
ANIMAL GENETICS MARKET, BY LIVE ANIMAL
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 7 Data Tables121
INCREASING FOCUS ON MAXIMIZING PRODUCTION EFFICIENCY TO
9.3.1
INCREASING APPLICATION OF ADVANCED GENETIC TECHNIQUES TO AID MARKET GROWTH
9.4.1
RISING AWARENESS OF GENETIC HEALTH IN DOGS TO SUPPORT GROWTH
9.5.1
RISING DEMAND FOR CHICKEN AND EGG AS PRIMARY PROTEIN SOURCES TO DRIVE MARKET
10
ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 31 Data Tables131
10.2
ANIMAL GENETIC MATERIALS
BOVINE SEMEN TO REGISTER HIGHEST GROWTH RATE DURING
10.2.1.2.1
RISING USE OF ARTIFICIAL INSEMINATION TO PROPEL MARKET GROWTH
10.2.1.3.1
STRINGENT REGULATIONS FOR DISEASE CONTROL TO POSE CHALLENGES FOR EQUINE INDUSTRY BREEDERS
INCREASING ADOPTION OF DOGS AS COMPANION ANIMALS TO
10.2.1.5
OTHER ANIMAL SEMEN
10.2.2.1.1
GROWING POPULARITY AMONG SEED STOCK AND BEEF PRODUCERS TO SUPPORT MARKET GROWTH
10.2.2.2.1
ARGENTINA, BRAZIL, AND US TO HOLD LEADING SHARES IN EMBRYO TRANSFER TECHNOLOGY
10.2.2.3
OTHER ANIMAL EMBRYOS
10.3
ANIMAL GENETIC TESTING SERVICES
10.3.1
GENETIC DISEASE TESTS
GENETIC DISEASE TESTS TO WITNESS HIGHEST GROWTH IN TESTING
10.3.2
GENETIC TRAIT TESTS
10.3.2.1
BOVINE GENETIC TRAIT TESTS
10.3.2.1.1
FOCUS ON HIGH-PRODUCTIVITY TRAITS IN HERDS TO DRIVE DEMAND
10.3.2.2
OTHER GENETIC TRAIT TESTS
10.3.3.1
EMPHASIS ON PARENTAGE IDENTIFICATION, ANIMAL REGISTRATION, AND GENDER-ASSOCIATED DISEASE IDENTIFICATION TO PROPEL MARKET
11
ANIMAL GENETICS MARKET, BY TECHNOLOGY
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 7 Data Tables163
11.2
NGS (NEXT-GENERATION SEQUENCING)
11.2.1
INCREASING APPLICATIONS IN AND RISING GLOBAL DEMAND FOR CHICKEN AND EGGS TO SUPPORT GROWTH
11.3
PCR (POLYMERASE CHAIN REACTION)
11.3.1
COST-EFFECTIVENESS, SIMPLICITY, AND HIGH ACCURACY TO DRIVE MARKET
11.4
RDNA (RECOMBINANT DNA TECHNOLOGY)
11.4.1
ABILITY TO SUPPORT GENETIC ENGINEERING AND GMOS TO SUPPORT MARKET GROWTH
11.5.1
RAPID ANALYTICAL CAPABILITIES TO PROPEL ADOPTION OF MICROARRAYS
12
ANIMAL GENETICS MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 6 Data Tables173
GROWING DEMAND FOR ANIMAL-DERIVED FOOD PRODUCTS TO
12.3
VETERINARY HOSPITALS & CLINICS
RISING INVESTMENTS AND TECHNOLOGICAL ADVANCEMENTS TO
12.4.1
RISING DEMAND FOR ACCURATE AND TIMELY DIAGNOSIS TO SUPPORT MARKET GROWTH
12.5.1
INCREASED FUNDING FOR RESEARCH AND GOVERNMENT INITIATIVES TO DRIVE MARKET
13
ANIMAL GENETICS MARKET, BY REGION
Comprehensive coverage of 9 Regions with country-level deep-dive of 18 Countries | 283 Data Tables.183
13.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
ADOPTION OF ADVANCED GENETIC TESTING METHODS TO DRIVE
13.2.3.1
GROWING DEMAND FOR GENETIC MATERIAL TO BOOST MARKET GROWTH
13.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
13.3.2.1
GROWING ADOPTION OF GENOMIC BREEDING AND SUSTAINABLE LIVESTOCK PRODUCTION DRIVES THE ANIMAL GENETICS MARKET
13.3.3.1
SELECTIVE BREEDING PROGRAMS AND EFFORTS TO IMPROVE BREED PRODUCTIVITY TO DRIVE DEMAND FOR ANIMAL GENETICS
13.3.4.1
GROWING DEMAND FOR LIVESTOCK AND POULTRY PRODUCTS DRIVES THE ANIMAL GENETICS MARKET
13.3.5.1
GOVERNMENT INITIATIVES TO CONSERVE INDIGENOUS BREEDS AND IMPROVE LIVESTOCK PRODUCTIVITY DRIVE MARKET GROWTH
13.3.6.1
RISING DEMAND FOR PORK AND POULTRY PRODUCTS SUPPORTS THE GROWTH OF THE ANIMAL GENETICS MARKET
13.3.7.1
STRONG LIVESTOCK SECTOR AND GROWING PRESENCE OF KEY MARKET PLAYERS TO DRIVE THE ANIMAL GENETICS MARKET
13.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
13.4.2.1
CHINA TO HOLD LARGEST SHARE OF ANIMAL GENETICS MARKET
13.4.3.1
LARGE DAIRY CATTLE POPULATION AND INCREASING DEMAND FOR SUPERIOR GENETICS DRIVE MARKET GROWTH
13.4.4.1
INCREASED PRODUCTION AND CONSUMPTION OF LIVESTOCK PRODUCTS TO DRIVE MARKET GROWTH
13.4.5.1
INCREASING DEMAND FOR ANIMAL-DERIVED FOOD PRODUCTS TO PROPEL MARKET GROWTH
13.4.6.1
GROWING DEMAND FOR PREMIUM ANIMAL PROTEIN AND ADVANCED BREEDING TECHNOLOGIES DRIVE MARKET GROWTH
13.4.7
REST OF ASIA PACIFIC
13.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
13.5.2.1
BRAZIL TO HOLD LARGEST SHARE OF LATAM MARKET
13.5.3.1
HIGH DEMAND FOR ANIMAL MEAT TO DRIVE MARKET GROWTH IN MEXICO
13.5.4
REST OF LATIN AMERICA
13.6
MIDDLE EAST & AFRICA
13.6.1
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
13.6.2.1
EMPHASIS ON IMPROVING ANIMAL WELFARE STANDARDS TO SUPPORT MARKET DEMAND
13.6.2.2
KINGDOM OF SAUDI ARABIA
13.6.2.2.1
KINGDOM OF SAUDI ARABIA TO HOLD THE LARGEST SHARE OF THE MIDDLE EAST ANIMAL GENETICS MARKET
13.6.2.3
UNITED ARAB EMIRATES
13.6.2.3.1
GROWING ADOPTION OF ANIMAL GENETICS TECHNOLOGIES IN UAE
13.6.2.4
REST OF GCC COUNTRIES
13.6.3
REST OF MIDDLE EAST AND AFRICA
14
COMPETITIVE LANDSCAPE
Discover which companies dominate the animal genetics market and their strategic paths to victory.295
14.2
KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, 2024–2026
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN
14.3
REVENUE ANALYSIS, 2023–2025
14.3.1
ANIMAL GENETICS MARKET: REVENUE ANALYSIS
14.4
MARKET SHARE ANALYSIS, 2025
14.4.1
GLOBAL SHARE ANALYSIS FOR ANIMAL GENETICS MARKET (2025)
14.4.2
US: SHARE ANALYSIS FOR ANIMAL GENETICS MARKET (2025)
14.4.3
EUROPE: SHARE ANALYSIS FOR ANIMAL GENETICS MARKET (2025)
14.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
14.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2025
14.5.5.1
COMPANY FOOTPRINT
14.5.5.2
REGION FOOTPRINT
14.5.5.3
LIVE ANIMALS FOOTPRINT
14.5.5.4
PRODUCT AND SERVICES FOOTPRINT
14.5.5.5
TECHNOLOGY FOOTPRINT
14.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
14.6.1
PROGRESSIVE COMPANIES
14.6.2
RESPONSIVE COMPANIES
14.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES
14.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
14.6.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
14.7
COMPANY VALUATION AND FINANCIAL METRICS
14.8
BRAND/PRODUCT COMPARISON
14.9
COMPETITIVE SCENARIO
14.9.1
PRODUCT LAUNCHES & APPROVALS
14.9.4
OTHER DEVELOPMENTS
15
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)324
15.1.1.1
BUSINESS OVERVIEW
15.1.1.2
PRODUCTS/SERVICE OFFERED
15.1.1.3
RECENT DEVELOPMENTS
15.1.1.3.1
PRODUCT/SERVICE LAUNCHES & APPROVALS
15.1.1.3.3
OTHER DEVELOPMENTS
15.1.1.4.2
STRATEGIC CHOICES
15.1.1.4.3
WEAKNESSES AND COMPETITIVE THREATS
15.1.2
NEOGEN CORPORATION
15.1.3
EUROFINS SCIENTIFIC
15.1.4
THERMO FISHER SCIENTIFIC INC
15.1.5
ZOETIS SERVICES LLC
15.1.7
HENDRIX GENETICS BV
15.1.11
SELECT SIRES INC.
15.1.13
QUANTUM GENETIX/BIOSCIENCES
15.1.14
ANIMAL GENETICS, INC.
15.2.1
LABOKLIN GMBH & CO. KG
15.2.3
TROPICAL ANIMAL GENETICS
15.2.4
INGURAN LLC DBA STGENETICS
15.2.5
SUPERIOR ANIMAL GENETICS
15.2.7
SWINE GENETICS INTERNATIONAL
15.2.9
GENSOL DIAGNOSTICS, LLC.
15.2.10
SANDOR ANIMAL BIOGENICS PVT. LTD.
16
RESEARCH METHODOLOGY
404
16.1.2.1
BREAKDOWN OF PRIMARY INTERVIEWS
16.1.2.2
KEY INDUSTRY INSIGHTS
16.2
MARKET SIZE ESTIMATION
16.2.1
APPROACH 1: COMPANY REVENUE ANALYSIS APPROACH
16.2.2
APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION
16.2.3
BOTTOM-UP APPROACH: SUPPLY-SIDE ANALYSIS
16.2.5
BASE NUMBER CALCULATION
16.2.5.1
COMPANY PRESENTATIONS
16.2.5.2
PRIMARY INTERVIEWS
16.2.7
DEMAND-SIDE APPROACH
16.3
MARKET BREAKDOWN AND DATA TRIANGULATION
16.4
MARKET SHARE ASSESSMENT
16.5
RESEARCH ASSUMPTIONS
16.5.2
GROWTH RATE ASSUMPTIONS
16.6.1
RESEARCH LIMITATIONS
17.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
17.3
CUSTOMIZATION OPTIONS
TABLE 1
ANIMAL GENETICS MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2
STANDARD CURRENCY CONVERSION RATES
TABLE 3
MILK PRODUCTION: PAST AND PROJECTED TRENDS IN DEVELOPING AND DEVELOPED COUNTRIES
TABLE 4
PER CAPITA CONSUMPTION OF MEAT: PAST AND PROJECTED TRENDS IN DEVELOPING AND DEVELOPED COUNTRIES
TABLE 5
WHITE SPACE OPPORTUNITIES IN ANIMAL GENETICS MARKET
TABLE 6
INTERCONNECTED MARKETS IN ANIMAL GENETICS MARKET
TABLE 7
CROSS SECTOR MARKETS IN ANIMAL GENETICS MARKET
TABLE 8
STRATEGIC MOVES BY TIER-1,2,3 PLAYERS IN ANIMAL GENETICS MARKET
TABLE 9
ANIMAL GENETICS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 10
GDP CHANGE, BY KEY COUNTRY, 2021–2030 (USD BILLION)
TABLE 11
AVERAGE SELLING PRICE TREND, BY KEY PLAYER, BY PRODUCT AND SERVICE MARKET (2023–2025) (USD)
TABLE 12
AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TECHNOLOGY, 2023−2025 (USD)
TABLE 13
AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END USER, 2023−2025 (USD)
TABLE 14
AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION, 2023−2025 (USD)
TABLE 15
IMPORT DATA FOR HS CODE 050110, BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 16
EXPORT DATA FOR HS CODE 051110, BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 17
ANIMAL GENETICS MARKET: MAJOR CONFERENCES & EVENTS IN 2026–2027
TABLE 18
ACCELERATING DAIRY CATTLE GENETIC IMPROVEMENT THROUGH GENOMIC TESTING
TABLE 19
IMPROVING SWINE PRODUCTIVITY THROUGH ADVANCED GENOMIC BREEDING
TABLE 20
ADVANCING POULTRY BREEDING THROUGH GENOMIC SELECTION AND PHENOTYPING
TABLE 21
US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 22
ASIA PACIFIC: IMPACT DUE TO THE US TARIFFS
TABLE 23
EUROPE: IMPACT DUE TO THE US TARIFFS
TABLE 24
ANIMAL GENETICS MARKET: MAJOR PATENTS
TABLE 25
KEY COMPANIES IMPLEMENTING AI IN ANIMAL GENETICS MARKET
TABLE 26
BEST PRACTICES IN ANIMAL GENETICS MARKET
TABLE 27
BEST PRACTICES IN CASE STUDIES OF AI IMPLEMENTATION IN ANIMAL GENETICS MARKET
TABLE 28
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
TABLE 29
NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 30
EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 31
ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 32
REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 33
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR ANIMAL GENETIC PRODUCTS & SERVICES
TABLE 34
KEY BUYING CRITERIA FOR ANIMAL GENETICS MARKET, BY END USERS
TABLE 35
ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 36
ANIMAL GENETICS MARKET FOR LIVE ANIMALS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 37
BOVINE GENETICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 38
PORCINE GENETICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 39
CANINE GENETICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 40
POULTRY GENETICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 41
OTHER LIVE ANIMAL GENETICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 42
ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 43
ANIMAL GENETIC PRODUCTS & SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 44
ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 45
ANIMAL GENETIC MATERIALS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 46
ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 47
ANIMAL GENETICS MARKET FOR SEMEN, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 48
CONVENTIONAL SEMEN VS. SEXED SEMEN: EVALUATION CRITERIA
TABLE 49
KEY PLAYERS OFFERING BOVINE SEMEN
TABLE 50
BOVINE SEMEN MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 51
KEY PLAYERS OFFERING PORCINE SEMEN
TABLE 52
PORCINE SEMEN MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 53
EQUINE SEMEN MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 54
CANINE SEMEN MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 55
ANIMAL GENETICS MARKET FOR OTHER ANIMAL SEMEN, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 56
ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 57
ANIMAL GENETICS MARKET FOR EMBRYOS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 58
ANIMAL GENETICS MARKET FOR BOVINE EMBRYOS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 59
ANIMAL GENETICS MARKET FOR EQUINE EMBRYOS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 60
ANIMAL GENETICS MARKET FOR OTHER ANIMAL EMBRYOS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 61
ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 62
ANIMAL GENETIC TESTING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 63
KEY GENETIC DISEASE TESTING SERVICES OFFERED, BY COMPANY
TABLE 64
GENETIC DISEASE TESTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 65
KEY GENETIC TRAIT TESTING SERVICES OFFERED, BY COMPANY
TABLE 66
GENETIC TRAIT TESTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 67
GENETIC TRAIT TESTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 68
BOVINE GENETIC TRAIT TESTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 69
OTHER GENETIC TRAIT TESTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 70
KEY DNA TYPING SERVICES OFFERED, BY COMPANY
TABLE 71
ANIMAL DNA TYPING MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 72
OTHER ANIMAL GENETICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 73
ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 74
ANIMAL GENETIC TECHNOLOGIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 75
ANIMAL GENETICS MARKET FOR NGS (NEXT GENERATION SEQUENCING), BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 76
ANIMAL GENETICS MARKET FOR PCR (POLYMERASE CHAIN REACTION), BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 77
ANIMAL GENETICS MARKET FOR RDNA (RECOMBINANT DNA TECHNOLOGY), BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 78
ANIMAL GENETICS MARKET FOR MICROARRAY, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 79
ANIMAL GENETICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 80
ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 81
ANIMAL GENETICS MARKET, BY END USER, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 82
ANIMAL GENETICS MARKET FOR ANIMAL FARMS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 83
ANIMAL GENETICS MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 84
ANIMAL GENETICS MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 85
ANIMAL GENETICS MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 86
ANIMAL GENETICS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 87
NORTH AMERICA: ANIMAL GENETICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 88
NORTH AMERICA: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 89
NORTH AMERICA: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 90
NORTH AMERICA: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 91
NORTH AMERICA: BOVINE GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (UNITS)
TABLE 92
NORTH AMERICA: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 93
NORTH AMERICA: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 94
NORTH AMERICA: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 95
NORTH AMERICA: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 96
NORTH AMERICA: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 97
NORTH AMERICA: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 98
US: MACROECONOMIC INDICATORS
TABLE 99
US: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 100
US: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 101
US: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 102
US: ANIMAL GENETIC MATERIALS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 103
US: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 104
US: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 105
US: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 106
US: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 107
US: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 108
CANADA: MACROECONOMIC INDICATORS
TABLE 109
CANADA: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 110
CANADA: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 111
CANADA: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 112
CANADA: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 113
CANADA: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 114
CANADA: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 115
CANADA: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 116
CANADA: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 117
CANADA: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 118
EUROPE: ANIMAL GENETICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 119
EUROPE: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 120
EUROPE: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 121
EUROPE: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 122
EUROPE: BOVINE GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (UNITS)
TABLE 123
EUROPE: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 124
EUROPE: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 125
EUROPE: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 126
EUROPE: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 127
EUROPE: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 128
EUROPE: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 129
GERMANY: MACROECONOMIC INDICATORS
TABLE 130
GERMANY: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 131
GERMANY: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 132
GERMANY: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 133
GERMANY: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 134
GERMANY: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 135
GERMANY: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 136
GERMANY: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 137
GERMANY: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 138
GERMANY: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 139
UK: MACROECONOMIC INDICATORS
TABLE 140
UK: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 141
UK: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 142
UK: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 143
UK: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 144
UK: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 145
UK: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 146
UK: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 147
UK: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 148
UK: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 149
FRANCE: MACROECONOMIC INDICATORS
TABLE 150
FRANCE: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 151
FRANCE: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 152
FRANCE: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 153
FRANCE: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 154
FRANCE: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 155
FRANCE: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 156
FRANCE: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 157
FRANCE: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 158
FRANCE: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 159
FRANCE: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 160
ITALY: MACROECONOMIC INDICATORS
TABLE 161
ITALY: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 162
ITALY: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 163
ITALY: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 164
ITALY: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 165
ITALY: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 166
ITALY: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 167
ITALY: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 168
ITALY: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 169
ITALY: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 170
SPAIN: MACROECONOMIC INDICATORS
TABLE 171
SPAIN: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 172
SPAIN: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 173
SPAIN: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 174
SPAIN: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 175
SPAIN: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 176
SPAIN: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 177
SPAIN: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 178
SPAIN: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 179
SPAIN: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 180
NETHERLANDS: MACROECONOMIC INDICATORS
TABLE 181
NETHERLANDS: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 182
NETHERLANDS: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 183
NETHERLANDS: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 184
NETHERLANDS: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 185
NETHERLANDS: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 186
NETHERLANDS: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 187
NETHERLANDS: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 188
NETHERLANDS: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 189
NETHERLANDS: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 190
REST OF EUROPE: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 191
REST OF EUROPE: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 192
REST OF EUROPE: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 193
REST OF EUROPE: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 194
REST OF EUROPE: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 195
REST OF EUROPE: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 196
REST OF EUROPE: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 197
REST OF EUROPE: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 198
REST OF EUROPE: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 199
ASIA PACIFIC: ANIMAL GENETICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 200
ASIA PACIFIC: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 201
ASIA PACIFIC: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 202
ASIA PACIFIC: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 203
ASIA PACIFIC: BOVINE GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (UNITS)
TABLE 204
ASIA PACIFIC: ANIMAL GENETICS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 205
ASIA PACIFIC: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 206
ASIA PACIFIC: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 207
ASIA PACIFIC: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 208
ASIA PACIFIC: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 209
ASIA PACIFIC: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 210
ASIA PACIFIC: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 211
CHINA: MACROECONOMIC INDICATORS
TABLE 212
CHINA: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 213
CHINA: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 214
CHINA: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 215
CHINA: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 216
CHINA: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 217
CHINA: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 218
CHINA: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 219
CHINA: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 220
CHINA: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 221
INDIA: MACROECONOMIC INDICATORS
TABLE 222
INDIA: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 223
INDIA: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 224
INDIA: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 225
INDIA: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 226
INDIA: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 227
INDIA: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 228
INDIA: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 229
INDIA: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 230
INDIA: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 231
JAPAN: MACROECONOMIC INDICATORS
TABLE 232
JAPAN: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 233
JAPAN: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 234
JAPAN: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 235
JAPAN: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 236
JAPAN: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 237
JAPAN: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 238
JAPAN: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 239
JAPAN: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 240
JAPAN: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 241
AUSTRALIA: MACROECONOMIC INDICATORS
TABLE 242
AUSTRALIA: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 243
AUSTRALIA: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 244
AUSTRALIA: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 245
AUSTRALIA: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 246
AUSTRALIA: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 247
AUSTRALIA: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 248
AUSTRALIA: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 249
AUSTRALIA: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 250
AUSTRALIA: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 251
SOUTH KOREA: MACROECONOMIC INDICATORS
TABLE 252
SOUTH KOREA: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 253
SOUTH KOREA: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 254
SOUTH KOREA: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 255
SOUTH KOREA: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 256
SOUTH KOREA: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 257
SOUTH KOREA: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 258
SOUTH KOREA: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 259
SOUTH KOREA: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 260
SOUTH KOREA: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 261
REST OF ASIA PACIFIC: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 262
REST OF ASIA PACIFIC: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 263
REST OF ASIA PACIFIC: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 264
REST OF ASIA PACIFIC: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 265
REST OF ASIA PACIFIC: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 266
REST OF ASIA PACIFIC: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 267
REST OF ASIA PACIFIC: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 268
REST OF ASIA PACIFIC: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 269
REST OF ASIA PACIFIC: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 270
LATIN AMERICA: ANIMAL GENETICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 271
LATIN AMERICA: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 272
LATIN AMERICA: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 273
LATIN AMERICA: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 274
LATIN AMERICA: BOVINE GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (UNITS)
TABLE 275
LATIN AMERICA: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 276
LATIN AMERICA: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 277
LATIN AMERICA: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 278
LATIN AMERICA: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 279
LATIN AMERICA: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 280
LATIN AMERICA: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 281
BRAZIL: MACROECONOMIC INDICATORS
TABLE 282
BRAZIL: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 283
BRAZIL: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 284
BRAZIL: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 285
BRAZIL: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 286
BRAZIL: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 287
BRAZIL: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 288
BRAZIL: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 289
BRAZIL: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 290
BRAZIL: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 291
MEXICO: MACROECONOMIC INDICATORS
TABLE 292
MEXICO: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 293
MEXICO: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 294
MEXICO: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 295
MEXICO: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 296
MEXICO: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 297
MEXICO: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 298
MEXICO: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 299
MEXICO: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 300
MEXICO: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 301
REST OF LATIN AMERICA: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 302
REST OF LATIN AMERICA: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 303
REST OF LATIN AMERICA: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 304
REST OF LATIN AMERICA: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 305
REST OF LATIN AMERICA: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 306
REST OF LATIN AMERICA: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 307
REST OF LATIN AMERICA: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 308
REST OF LATIN AMERICA: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 309
REST OF LATIN AMERICA: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 310
MIDDLE EAST & AFRICA: ANIMAL GENETICS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 311
MIDDLE EAST & AFRICA: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 312
MIDDLE EAST & AFRICA: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 313
MIDDLE EAST & AFRICA: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 314
MIDDLE EAST & AFRICA: BOVINE GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (UNITS)
TABLE 315
MIDDLE EAST & AFRICA: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 316
MIDDLE EAST & AFRICA: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 317
MIDDLE EAST & AFRICA: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 318
MIDDLE EAST & AFRICA: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 319
MIDDLE EAST & AFRICA: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 320
MIDDLE EAST & AFRICA: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 321
GCC COUNTRIES: ANIMAL GENETICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 322
GCC COUNTRIES: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 323
GCC COUNTRIES: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 324
GCC COUNTRIES: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 325
GCC COUNTRIES: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 326
GCC COUNTRIES: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 327
GCC COUNTRIES: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 328
GCC COUNTRIES: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 329
GCC COUNTRIES: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 330
GCC COUNTRIES: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 331
KINGDOM OF SAUDI ARABIA: MACROECONOMIC INDICATORS
TABLE 332
KINGDOM OF SAUDI ARABIA: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 333
KINGDOM OF SAUDI ARABIA: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 334
KINGDOM OF SAUDI ARABIA: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 335
KINGDOM OF SAUDI ARABIA: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 336
KINGDOM OF SAUDI ARABIA: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 337
KINGDOM OF SAUDI ARABIA: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 338
KINGDOM OF SAUDI ARABIA: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 339
KINGDOM OF SAUDI ARABIA: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 340
KINGDOM OF SAUDI ARABIA: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 341
UNITED ARAB EMIRATES: MACROECONOMIC INDICATORS
TABLE 342
UNITED ARAB EMIRATES: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 343
UNITED ARAB EMIRATES: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 344
UNITED ARAB EMIRATES: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 345
UNITED ARAB EMIRATES: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 346
UNITED ARAB EMIRATES: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 347
UNITED ARAB EMIRATES: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 348
UNITED ARAB EMIRATES: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 349
UNITED ARAB EMIRATES: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 350
UNITED ARAB EMIRATES: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 351
REST OF GCC COUNTRIES: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 352
REST OF GCC COUNTRIES: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 353
REST OF GCC COUNTRIES: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 354
REST OF GCC COUNTRIES: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 355
REST OF GCC COUNTRIES: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 356
REST OF GCC COUNTRIES: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 357
REST OF GCC COUNTRIES: ANIMAL GENETIC TRAIT TESTS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 358
REST OF GCC COUNTRIES: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 359
REST OF GCC COUNTRIES: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 360
REST OF MIDDLE EAST & AFRICA: ANIMAL GENETICS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 361
REST OF MIDDLE EAST & AFRICA: ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE, 2024–2031 (USD MILLION)
TABLE 362
REST OF MIDDLE EAST & AFRICA: ANIMAL GENETIC MATERIALS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 363
REST OF MIDDLE EAST & AFRICA: ANIMAL GENETICS MARKET FOR SEMEN, BY TYPE, 2024–2031 (USD MILLION)
TABLE 364
REST OF MIDDLE EAST & AFRICA: ANIMAL GENETICS MARKET FOR EMBRYOS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 365
REST OF MIDDLE EAST & AFRICA: ANIMAL GENETIC TESTING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 366
REST OF MIDDLE EAST & AFRICA: ANIMAL GENETIC TRAIT TESTS MARKET, BY LIVE ANIMAL, 2024–2031 (USD MILLION)
TABLE 367
REST OF MIDDLE EAST & AFRICA: ANIMAL GENETICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 368
REST OF MIDDLE EAST & AFRICA: ANIMAL GENETICS MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 369
OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN ANIMAL GENETICS MARKET, JANUARY 2023–JUNE 2026
TABLE 370
ANIMAL GENETICS MARKET: DEGREE OF COMPETITION, 2025
TABLE 371
US ANIMAL GENETICS MARKET: DEGREE OF COMPETITION, 2025
TABLE 372
EUROPE: ANIMAL GENETICS MARKET: DEGREE OF COMPETITION, 2025
TABLE 373
ANIMAL GENETICS MARKET: REGION FOOTPRINT
TABLE 374
ANIMAL GENETICS MARKET: LIVE ANIMALS FOOTPRINT
TABLE 375
ANIMAL GENETICS MARKET: PRODUCT AND SERVICES FOOTPRINT
TABLE 376
ANIMAL GENETICS MARKET: TECHNOLOGY FOOTPRINT
TABLE 377
ANIMAL GENETICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2025
TABLE 378
ANIMAL GENETICS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUP/SME PLAYERS, 2025
TABLE 379
ANIMAL GENETICS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JUNE 2026
TABLE 380
ANIMAL GENETICS MARKET: DEALS, JANUARY 2023–JUNE 2026
TABLE 381
ANIMAL GENETICS MARKET: EXPANSIONS, JANUARY 2023–JUNE 2026
TABLE 382
ANIMAL GENETICS MARKET: OTHER DEVELOPMENTS, JANUARY 2023–JUNE 2026
TABLE 383
GENUS PLC: COMPANY OVERVIEW
TABLE 384
GENUS PLC: PRODUCTS/SERVICES OFFERED
TABLE 385
GENUS PLC: PRODUCT/SERVICE LAUNCHES & APPROVALS
TABLE 386
GENUS PLC: DEALS
TABLE 387
GENUS PLC: OTHER DEVELOPMENTS
TABLE 388
NEOGEN CORPORATION: COMPANY OVERVIEW
TABLE 389
NEOGEN CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 390
NEOGEN CORPORATION: PRODUCT/SERVICE LAUNCHES & APPROVALS
TABLE 391
NEOGEN CORPORATION: DEALS
TABLE 392
NEOGEN CORPORATION: EXPANSIONS
TABLE 393
EUROFINS SCIENTIFIC: COMPANY OVERVIEW
TABLE 394
EUROFINS SCIENTIFIC: PRODUCTS/SERVICES OFFERED
TABLE 395
EUROFINS SCIENTIFIC: DEALS
TABLE 396
THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
TABLE 397
THERMO FISHER SCIENTIFIC INC: PRODUCTS/SERVICES OFFERED
TABLE 398
THERMO FISHER SCIENTIFIC INC: PRODUCT/SERVICE LAUNCHES & APPROVALS
TABLE 399
ZOETIS SERVICES LLC: COMPANY OVERVIEW
TABLE 400
ZOETIS: PRODUCTS/SERVICES OFFERED
TABLE 401
ZOETIS SERVICES LLC: PRODUCT & SERVICE LAUNCHES
TABLE 402
ZOETIS SERVICES LLC: DEALS
TABLE 403
ZOETIS SERVICES LLC: OTHER DEVELOPMENTS
TABLE 404
ILLUMINA, INC.: COMPANY OVERVIEW
TABLE 405
ILLUMINA, INC.: PRODUCTS/SERVICES OFFERED
TABLE 406
HENDRIX GENETICS BV: COMPANY OVERVIEW
TABLE 407
HENDRIX GENETICS BV: PRODUCTS/SERVICES OFFERED
TABLE 408
HENDRIX GENETICS BV: PRODUCT & SERVICE LAUNCHES
TABLE 409
HENDRIX GENETICS BV: DEALS
TABLE 410
HENDRIX GENETICS BV: EXPANSIONS
TABLE 411
HENDRIX GENETICS BV: OTHER DEVELOPMENTS
TABLE 412
CRV: COMPANY OVERVIEW
TABLE 413
CRV: PRODUCTS/SERVICES OFFERED
TABLE 414
CRV: PRODUCT/SERVICE LAUNCHES & APPROVALS
TABLE 416
TOPIGS NORSVIN EN: COMPANY OVERVIEW
TABLE 417
TOPIGS NORSVIN EN: PRODUCTS/SERVICES OFFERED
TABLE 418
TOPIGS NORSVIN EN: PRODUCT/SERVICE LAUNCHES & APPROVALS
TABLE 419
TOPIGS NORSVIN EN: DEALS
TABLE 420
TOPIGS NORSVIN EN: EXPANSIONS
TABLE 421
TOPIGS NORSVIN EN: OTHER DEVELOPMENTS
TABLE 422
URUS GROUP LP: COMPANY OVERVIEW
TABLE 423
URUS GROUP LP: PRODUCTS/SERVICES OFFERED
TABLE 424
URUS GROUP LP: PRODUCT/SERVICE LAUNCHES & APPROVALS
TABLE 425
URUS GROUP LP: DEALS
TABLE 426
URUS GROUP LP: EXPANSIONS
TABLE 427
SELECT SIRES INC.: COMPANY OVERVIEW
TABLE 428
SELECT SIRES INC: PRODUCTS/SERVICES OFFERED
TABLE 429
SELECT SIRES INC: PRODUCT/SERVICE LAUNCHES & APPROVALS
TABLE 430
SELECT SIRES INC.: DEALS
TABLE 431
GROUPE GRIMAUD: COMPANY OVERVIEW
TABLE 432
GROUPE GRIMAUD: PRODUCTS/SERVICES OFFERED
TABLE 433
GROUPE GRIMAUD: EXPANSIONS
TABLE 434
GROUPE GRIMAUD: OTHER DEVELOPMENTS
TABLE 435
QUANTUM GENETIX/BIOSCIENCES: COMPANY OVERVIEW
TABLE 436
QUANTUM GENETIX/BIOSCIENCES: PRODUCTS/SERVICES OFFERED
TABLE 437
QUANTUM GENETIX/BIOSCIENCES: OTHER DEVELOPMENTS
TABLE 438
ANIMAL GENETICS INC.: COMPANY OVERVIEW
TABLE 439
ANIMAL GENETICS INC.: PRODUCTS/SERVICES OFFERED
TABLE 440
SEMEX: COMPANY OVERVIEW
TABLE 441
SEMEX: PRODUCTS/SERVICES OFFERED
TABLE 443
SEMEX: EXPANSIONS
TABLE 444
STUDY ASSUMPTIONS
TABLE 445
ANIMAL GENETICS MARKET: RISK ASSESSMENT ANALYSIS
FIGURE 1
ANIMAL GENETICS MARKET: SEGMENTS CONSIDERED
FIGURE 3
GLOBAL ANIMAL GENETICS MARKET, 2024–2031
FIGURE 4
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN ANIMAL GENETICS MARKET, 2024–2026
FIGURE 5
DISRUPTIONS INFLUENCING GROWTH OF ANIMAL GENETICS MARKET
FIGURE 6
HIGH-GROWTH SEGMENTS IN ANIMAL GENETICS MARKET, 2026–2031
FIGURE 7
ASIA PACIFIC TO REGISTER HIGHEST CAGR IN ANIMAL GENETICS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
FIGURE 8
GROWING ADOPTION OF GENETIC TESTING TO DRIVE MARKET GROWTH
FIGURE 9
ANIMAL FARMS SEGMENT IN ASIA PACIFIC REGION ACCOUNTED FOR LARGEST SHARE IN 2025
FIGURE 10
INDIA TO WITNESS HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 11
ANIMAL GENETICS MARKET: MARKET DYNAMICS
FIGURE 12
ANIMAL GENETICS MARKET: PORTER'S FIVE FORCES ANALYSIS
FIGURE 13
SUPPLY CHAIN ANALYSIS
FIGURE 14
ANIMAL GENETICS PRODUCT AND SERVICE MANUFACTURING & RESEARCH MARKET: VALUE CHAIN ANALYSIS
FIGURE 15
ANIMAL GENETICS MARKET: ECOSYSTEM ANALYSIS
FIGURE 16
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 17
INVESTMENT & FUNDING SCENARIO, 2023–2026
FIGURE 18
ANIMAL GENETICS MARKET: NUMBER OF GRANTED PATENT APPLICATIONS, JANUARY 2016–MAY 2026
FIGURE 19
TOP APPLICANT COUNTRIES/REGIONS FOR ANIMAL GENETIC PRODUCTS& SERVICES PATENTS, JANUARY 2016–JUNE 2026
FIGURE 20
KEY FEATURES OF AI/GENERATIVE AI IN ANIMAL GENETICS MARKET
FIGURE 21
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR ANIMAL GENETIC PRODUCTS & SERVICES
FIGURE 22
KEY BUYING CRITERIA FOR ANIMAL GENETICS MARKET, BY END USER
FIGURE 23
NORTH AMERICA: ANIMAL GENETICS MARKET SNAPSHOT
FIGURE 24
ASIA PACIFIC: ANIMAL GENETICS MARKET SNAPSHOT
FIGURE 25
REVENUE ANALYSIS OF KEY PLAYERS IN ANIMAL GENETICS MARKET, 2023–2025 (USD MILLION)
FIGURE 26
GLOBAL MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025
FIGURE 27
US: SHARE ANALYSIS FOR ANIMAL GENETICS MARKET, 2025
FIGURE 28
EUROPE: SHARE ANALYSIS FOR ANIMAL GENETICS MARKET, 2025
FIGURE 29
ANIMAL GENETICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 30
ANIMAL GENETICS MARKET: COMPANY FOOTPRINT, 2025
FIGURE 31
ANIMAL GENETICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 32
EV/EBITDA OF KEY VENDORS FOR ANIMAL GENETICS, 2025
FIGURE 33
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS FOR ANIMAL GENETICS, 2025
FIGURE 34
ANIMAL GENETICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 35
GENUS PLC: COMPANY SNAPSHOT (2025)
FIGURE 36
NEOGEN CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 37
EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2025)
FIGURE 38
THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025)
FIGURE 39
ZOETIS SERVICES LLC: COMPANY SNAPSHOT (2025)
FIGURE 40
ILLUMINA, INC.: COMPANY SNAPSHOT (2025)
FIGURE 41
ANIMAL GENETICS MARKET: RESEARCH DESIGN
FIGURE 42
KEY DATA FROM SECONDARY SOURCES
FIGURE 43
PRIMARY SOURCES
FIGURE 44
KEY DATA FROM PRIMARY SOURCES
FIGURE 45
KEY INDUSTRY INSIGHTS
FIGURE 46
BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 47
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 48
BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND-SIDE PARTICIPANTS
FIGURE 49
RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 50
MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
FIGURE 51
REVENUE SHARE ANALYSIS ILLUSTRATION: GENUS PLC (2025)
FIGURE 52
BOTTOM-UP APPROACH
FIGURE 53
TOP-DOWN APPROACH
FIGURE 54
SUPPLY-SIDE ANALYSIS: ANIMAL GENETICS MARKET (2025)
FIGURE 55
DEMAND-SIDE APPROACH
FIGURE 56
ANIMAL GENETICS MARKET: CAGR PROJECTION FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2026–2031)
FIGURE 57
CAGR PROJECTION: SUPPLY-SIDE ANALYSIS
FIGURE 58
MARKET DATA TRIANGULATION METHODOLOGY
Methodology
Secondary research was conducted to gather information for this technical, market-oriented, and commercial study of the global animal genetics market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Different approaches, such as top-down and bottom-up, were used to estimate the total market size. After that, market breakup and data triangulation procedures were used to estimate the size of the segments and subsegments of the animal genetics market.
Secondary ResearchIn the secondary research process, various secondary sources were consulted to identify and collect information for the study. These sources included annual reports, press releases, and investor presentations; regulatory filings; clinical literature and peer-reviewed journals; related association publications; certified publications; and white papers. Secondary research was primarily used to obtain key information on the industry's supply chain, the total pool of key players, market classification and segmentation according to industry trends down to the most granular level, regional markets, and key developments from both market- and technology-oriented perspectives. Primary sources further validated all this information.
Primary ResearchIn the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included CEOs, vice presidents, business development directors, marketing directors, R&D heads, genomics specialists, breeding program managers, and other key executives from companies operating in the animal genetics market. Primary sources from the demand side included livestock producers, breeding organizations, veterinarians, veterinary surgeons, diagnostic laboratories, research institutes, universities, and government organizations involved in animal breeding and genetic improvement. Primary research was conducted to validate the market segmentation, identify key players, and gather insights into industry trends, technological advancements, and market dynamics.
In the market engineering process, top-down and bottom-up approaches were extensively used, along with multiple data triangulation methods, to estimate and forecast the overall market as well as its segments and subsegments. Extensive qualitative and quantitative analyses were conducted throughout the market engineering process to provide comprehensive market estimates and strategic insights.
Following the market engineering process, including market size estimation, forecasting, market breakdown, and data triangulation, extensive primary research was conducted to verify and validate the final market estimates. Primary interviews were also used to confirm the market segmentation, competitive landscape, adoption of genomic and reproductive technologies, regional trends, and key market dynamics, including drivers, restraints, opportunities, challenges, and strategic developments within the animal genetics market.
Note 1: Others include veterinarians, breeding managers, livestock producers, genomics specialists, and diagnostic laboratory professionals
Note 2: Tier 1 companies – revenue higher than USD 10 billion; Tier 2 companies – revenue between USD 1 and 10 billion; Tier 3 companies – revenue between USD 500 million and USD 1 billion.
Note 3: The breakup above represents an indicative list of primary profiles.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Top-down and bottom-up approaches were used to estimate and validate the size of the animal genetics market and the sizes of various dependent subsegments within the overall market. The research methodology used to estimate market size includes the following: key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This procedure included reviewing the annual and financial reports of the top market players, along with extensive interviews with key industry leaders, such as CEOs, VPs, directors, and marketing executives, to gain key insights.
All percentage splits and breakdowns were determined using secondary sources and verified through primary sources. All possible parameters that affect the market covered in this research study have been accounted for, examined in extensive detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data. This data is consolidated and combined with detailed input and analysis from MarketsandMarkets.
Infographic Depicting Bottom-Up and Top-Down Approaches
Data Triangulation
After determining the overall market size using the market size estimation processes explained above, the market was segmented into several segments and subsegments. Data triangulation and market breakup procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for each market segment and subsegment. The data was triangulated by analyzing various factors and trends from both the demand and supply sides.
Market Definition
The animal genetics market comprises products, services, and technologies used to improve the genetic characteristics of livestock and companion animals through selective breeding, assisted reproductive technologies, and molecular genetics. The market includes genetic materials, such as semen, embryos, and ova, along with genetic testing services including disease susceptibility testing, genetic trait testing, parentage verification, breed identification, DNA typing, and genomic analysis. It also encompasses enabling technologies such as Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Recombinant DNA (rDNA) technology, microarrays, SNP genotyping, microsatellite (STR) analysis, and Sanger sequencing, which facilitate genetic evaluation and selection. These products and services are used across bovine, porcine, poultry, aquaculture, equine, canine, feline, ovine, caprine, and other animal species by animal farms, veterinary hospitals & clinics, diagnostic centers, and research institutes to enhance productivity, fertility, disease resistance, product quality, and the long-term sustainability of animal breeding programs.
Key Stakeholders
- Animal genetic materials producers (semen and embryo suppliers)
- Animal genetic testing service providers and diagnostic laboratories
- Animal breeding cooperatives and breed societies
- Livestock farms and integrators across poultry, swine, bovine, and other species
- Veterinary hospitals and clinics
- Companion animal breeders and kennel/cattery associations
- Research institutes and veterinary organizations
- Government bodies and regulatory authorities
- Investors and private equity firms focused on animal health and biotechnology
- Distributors and channel partners for genetic materials
Report Objectives
- To define, describe, and forecast the animal genetics market by live animal, product & service, technology, end user, and region from 2026 to 2031, and to analyze the various macroeconomic and microeconomic factors that affect market growth
- To forecast the market size of five main regions: North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America.
- To analyze the subsegments of the market with respect to individual growth trends, prospects, and contributions to the overall market.
- To provide detailed information regarding the major factors (drivers, restraints, opportunities, and challenges) influencing market growth.
- To analyze opportunities in the market for stakeholders and to provide details of the competitive landscape of major players.
- To profile key market players and comprehensively analyze their business overviews, regional presence, product offerings, business strategies, and key financials, and to illustrate the competitive landscape of the market.
- To analyze competitive developments such as mergers & acquisitions, product launches, partnerships and collaborations, and research & development (R&D) activities in the market.
Available customizations:
With the given market data, MarketsandMarkets offers customizations based on company-specific needs. The following customization options are available for the report:
Geographic Analysis- Further breakup of the market in the Rest of Asia Pacific, by country
- Further breakup of the market in the Rest of Europe, by country
- Further breakup of the market in the Rest of Latin America, by country
-
Further breakup of the market in the Rest of Middle East & Africa, by country
Company Information
-
- Detailed analysis and profiling of additional market players (up to 5).
-
Personalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Animal Genetics Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Director of Market Insights, Data and Analytics
SFI Health,
Leading Pharmaceutical Company
We at SFI Health approached MarketsandMarkets for an Opportunity Assessment on "Incidence and Prevalence of Focus Indications" as we wanted to know the most attractive HCPs like Physician, Functional MD, Naturopath and Pharmacist. The project was critical for us to ensure our focus on the right target which would enable sustainable growth and profitability for SFI Health. The business insights provided exceeded our expectations and we were extremely impressed. The team at MarketsandMarkets is highly professional and detail oriented and very well understood our business needs. MarketsandMarkets offers a unique combination of expertise and dedicated engagement model. We identified 2 new products to be launched in coming months, based on the research findings provided by MarketsandMarkets. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
Head of Commercial Analytics
Qualicaps,
Leading Pharmaceutical Company
We partnered with MarketsandMarkets for an assessment study on hard empty capsules. The team was extremely professional in understanding our business requirements and we received timely responses to all our queries. The market intelligence and the recommendations has met our business requirements. We were extremely impressed to see the final study results; it really exceeded our expectations. The market intelligence offered by MarketsandMarkets, and clarity on next steps will help us achieve our business objective for the Year 2021. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
Senior Director Business Development & Innovation
Bracco Diagnostics Inc.,
Italian Multinational in life sciences sector and a World Leader in imaging diagnostics
We were pleased with targeted insights that MarketsandMarkets identified from a custom study on the 'Radiation Dose Management Solutions Market'. Your team identified and characterized the market participants as well as underlying trends accurately. This study was useful to Bracco in formulating business strategies for our dose monitoring product lines and we thank MarketsandMarkets for the job well done.
Market Development and Strategy Manager
3M Health Information Systems,
Leader in Health care Coding, Payment & Analytics Solutions.
The value for our organization comes from three things: depth of research, specificity of segments and being easy to work with. As important as the first two are, the third can't be underestimated. MarketsandMarkets, maybe more than any other research vendor, wants to know what is top of mind for our team and what big questions we are grappling to answer.
Their customer first approach and high value engagement model, have given us great analysis and excellent value for money
Схожие новости
Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 9.33. Источник: www.marketsandmarkets.com.